Literature DB >> 26697906

Finding the Path to Biobank Sustainability Through Sound Business Planning.

Marianne Henderson1, Daniel Simeon-Dubach2, Monique Albert3.   

Abstract

Mesh：

Year:  2015        PMID： 26697906      PMCID： PMC4697354          DOI： 10.1089/bio.2015.29039.mh

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN： 1947-5543            Impact factor:   2.300


× No keyword cloud information.
  4 in total

1.  Drug development: Raise standards for preclinical cancer research.

Authors:  C Glenn Begley; Lee M Ellis
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

2.  Believe it or not: how much can we rely on published data on potential drug targets?

Authors:  Florian Prinz; Thomas Schlange; Khusru Asadullah
Journal:  Nat Rev Drug Discov       Date:  2011-08-31       Impact factor: 84.694

3.  Sustainability in biobanking.

Authors:  Daniel Simeon-Dubach; Marianne K Henderson
Journal:  Biopreserv Biobank       Date:  2014-10-14       Impact factor: 2.300

4.  The Economics of Reproducibility in Preclinical Research.

Authors:  Leonard P Freedman; Iain M Cockburn; Timothy S Simcoe
Journal:  PLoS Biol       Date:  2015-06-09       Impact factor: 8.029
  4 in total
  9 in total

1.  Advancing Professionalization of Biobank Business Operations: Performance and Utilization.

Authors:  Marianne K Henderson; Kirstin Goldring; Daniel Simeon-Dubach
Journal:  Biopreserv Biobank       Date:  2019-06       Impact factor: 2.300

2.  Achieving and Maintaining Sustainability in Biobanking Through Business Planning, Marketing, and Access.

Authors:  Marianne K Henderson; Kirstin Goldring; Daniel Simeon-Dubach
Journal:  Biopreserv Biobank       Date:  2016-11-18       Impact factor: 2.300

3.  Trends in Biobanking Business Planning: Initial Results of a Survey of Biobankers.

Authors:  Daniel Simeon-Dubach; Kirstin Goldring; Marianne K Henderson
Journal:  Biopreserv Biobank       Date:  2016-12-12       Impact factor: 2.300

Review 4.  Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.

Authors:  Daniel Simeon-Dubach; Marianne K Henderson
Journal:  Biopreserv Biobank       Date:  2020-10-08       Impact factor: 2.300

5.  Biobank and Pathology Facility: A Successful Combination.

Authors:  Adriana Alves; Amanda Gibbon; Sara Carvalho; Manuel Rodriguez-Justo; Elena Miranda
Journal:  J Biomol Tech       Date:  2022-02-02

6.  Biospecimen User Fees: Global Feedback on a Calculator Tool.

Authors:  Lise A M Matzke; Sindy Babinszky; Alex Slotty; Anna Meredith; Tania Castillo-Pelayo; Marianne K Henderson; Daniel Simeon-Dubach; Brent Schacter; Peter H Watson
Journal:  Biopreserv Biobank       Date:  2016-08-30       Impact factor: 2.300

7.  Business Planning in Biobanking: How to Implement a Tool for Sustainability.

Authors:  Mirella Ciaburri; Mariarosaria Napolitano; Elena Bravo
Journal:  Biopreserv Biobank       Date:  2016-11-29       Impact factor: 2.300

8.  Assessing and measuring financial sustainability model of the Spanish HIV HGM BioBank.

Authors:  Irene Consuegra Fernández; Isabel García Merino; María Ángeles Muñoz-Fernández
Journal:  J Transl Med       Date:  2020-01-06       Impact factor: 5.531

9.  Transformation of the Taiwan Biobank 3.0: vertical and horizontal integration.

Authors:  Jui-Chu Lin; Wesley Wei-Wen Hsiao; Chien-Te Fan
Journal:  J Transl Med       Date:  2020-08-06       Impact factor: 5.531
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.